Delivery Order SPE2DB22D3401-SPE2DB25FT1YF

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,818,331 units of Lupron Depot 45 mg 6-month kits. The contract has a ceiling value of $4,206.70 and a completion date of September 17, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,694.94 firm fixed-price contract is for the delivery of 4,566,796,274 units of the drug Lupron Depot 3.75 mg kits. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,660,007 units of Lupron Depot 11.25 mg 3-month kits, a medication used in the treatment of certain medical conditions. The contract has a ceiling value of $8,559.53 and a period of performance through May 21, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,170.94, is for the delivery of 4,566,340,729 units of Lupron Depot 11.25 mg 3-month kits. The contract has a firm-fixed price pricing type and a period of performance through November 6, 2024. This contract is a delivery order and was not designated with a set-aside. AmerisourceBergen holds a...
This is a delivery order issued under a prime contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $28,118.80, is for Lupron Depot 11.25 mg 3-month kits, a specialty medication. The contract has a period of performance through February 4, 2025 and is a firm fixed-price type contract. This award is not associated with a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Lupron Depot 11.25 mg 3-month kits, a pharmaceutical product, with a ceiling value of $11,404.11. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a single-award IDC with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LUPRON DEPOT 45 MG 6MO KITS. The contract has a ceiling value of $4,458.35 and will run through January 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $2,417.80 and an ultimate completion date of May 1, 2024. Amerisourcebergen is the prime contractor, and the parent company is Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot 3.75 MG kits. The contract has a firm fixed price of $10,907.04 and an ultimate completion date of March 9, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lupron Depot 3.75 mg kits, a specialty medication. The contract has a firm fixed price of $1,872.85 and a period of performance through July 29, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for the...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT1YF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $8,947.42 and runs through February 6, 2025. It is a firm-fixed-price contract with no set-aside requirements, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/7/25, 9:48 AM